1

Two Glenmark drugs inch towards clinical trials

Two new chemical entities (NCE) of Glenmark Pharmaceuticals in the anti-obesity and pain segments are set to enter the clinical trial stage in October this year, bolstering the company's already strong discovery pipeline. Read »
Created by raja Created 11 weeks 2 days ago – Made popular 11 weeks 2 days ago
Category: Business   Tags:

Similar stories

Glenmark's pain molecule enters clinical trial Created 7 weeks 2 days ago
Glenmark will launch 5 drugs a quarter in the US Created 18 weeks 6 hours ago
'At least eight molecules will see clinical trials this year' Created 10 weeks 4 days ago
Neuland clinical-trials foray by Nov Created 13 weeks 2 days ago
Glenmark acquires 7 pharmaceutical brands in Poland Created 9 weeks 1 day ago
Shortage of guinea pigs hits clinical trials in India Created 8 weeks 4 days ago
Suven mulls new unit for molecules Created 22 weeks 2 days ago

User login

Syndicate

Syndicate content